Stocks to watch: Keppel Reit, Mapletree Logistics Trust, First Reit, Singapore banks

21 Jul 2020 - The Business Times
THE following companies saw new developments that may affect trading of their securities on Tuesday: Keppel Reit: Its distribution per unit (DPU) of 1.4 Singapore cents for the second quarter this year is a notch above its DPU of 1.39 cents for the same period a year ago. This was despite net property ...
sgx:m44u sgx:8yy sgx:bn4 sgx:d05 sgx:40v sgx:t39 sgx:k71u sgx:j91u sgx:m1gu sgx:o39 sgx:u11

---

DSS Announces Update On the Acquisition of Impact Biomedical - GlobeNewswire

15 Jul 2020 - GlobeNewswire

sgx:40v usx:dss

---

Singapore shares drift up, with eyes on GE2020 campaign

1 Jul 2020 - The Business Times
SINGAPORE shares ended Wednesday on a firmer note, but trading interest was light, with some brokers spending their time following the various ‘live coverages’ of the campaigning for the general election here. In all, 191 candidates from 11 political parties and an independent candidate will contest ...
sgx:d05 sgx:40v sgx:e28 klse:0080 sgx:o39 sgx:s68 sgx:u11

---

Singapore eDevelopment shares surged as high as 79% following news of its success against Covid-19 with its biotechnologies

24 Jun 2020 - The Edge Markets
SINGAPORE (June 24): Shares in Singapore eDevelopment (SeD) surged as high as 79% to 10 cents following its announcement of its in-vitro success against Covid-19 with its biotechnologies. Earlier today, SeD’s wholly-owned subsidiary Impact Biomedical said it has successfully proved in-vitro success of ...
sgx:40v

---

Singapore eDevelopment : Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragrance - marketscreener.com

24 Jun 2020 - Market Screener

sgx:40v

---

Document Security Systems (DSS) on Watch as Target Company Announces Positive COVID Results - StreetInsider.com

24 Jun 2020 - StreetInsider.com

sgx:40v usx:dss

---

Singapore eDevelopment subsidiary discovers potential medicines to inhibit Covid-19 in peer-reviewed scientific journal

17 Jun 2020 - The Edge Markets
SINGAPORE (June 17): Singapore eDevelopment’s (SeD) wholly-owned subsidiary Impact Biomedical says that its Covid-19 research with Global Research and Discovery Group Sciences (GRDG) was published in the peer-reviewed scientific journal Molecules on June 11. The research was conducted in collaboration ...
sgx:40v

---

Singapore eDevelopment : Impact Biomedical Announces Publication of COVID-19 Research in Peer-Reviewed Journal - marketscreener.com

17 Jun 2020 - Market Screener

sgx:40v sgx:566

---

Impact Biomedical Announces Publication of COVID-19 Research in Peer-Reviewed Journal - Benzinga

17 Jun 2020 - Benzinga

sgx:40v

---

Tetra Bio-Pharma and Altus Formulation Form New Company "TALLC" to Exploit TA-A001 - Stock Day Media

3 Jun 2020 - Stock Day Media

sgx:40v

---